Nucleic Acid Amplification Testing Market Analysis By Application (Infectious Diseases, Cancer, Personalized Medicine, Genetic), By Technique (target amplification, probe amplification, & signal amplification), And Segment Forecasts, 2014 - 2025

Published: Feb, 2017 | Pages: 90 | Publisher: Grand View Research
Industry: Healthcare | Report Format: Electronic (PDF)

The global nucleic acid amplification test (NAAT) market is expected to reach USD 4.4 Billion by 2025, according to a new report by Grand View Research, Inc. Nucleic acid amplification testing is gaining preference over traditional diagnostic techniques because of its high efficiency and accuracy. In addition, the potential application of these tests in various life-threatening diseases, including several types of cancer, is attracting a large amount of investment for the purpose of R&D. Increasing number of ongoing studies are expected to ensure higher growth rate in the later part of the forecast period.

These tests are currently being used extensively for screening and diagnosis of a wide range of infectious diseases. Along with known infectious diseases, management of epidemics of new diseases has caused a sudden surge in the demand for advanced diagnostic tests. NAAT is currently the most advanced and efficient diagnostic method, which extensively uses technology that helps in reducing procedural time and consumption of reagents.

Further Key Findings from the Study Suggest:

The market study suggests that infectious diseases segment captured the largest revenue share in 2015 owing to the high demand for effective screening methods for management of these diseases

Cancer is expected to exhibit the fastest growth during the forecast period due to the rising number of studies to develop tests for early detection of various cancer types

Expanding applications prenatal screening and for the detection of mitochondrial disorders is expected to boost the demand for NAAT

High usage of the PCR technique in NAT is driving the growth of the segment and is expected to capture significant revenue share in the near future

North America dominated the space in 2015 with U.S. capturing the largest share

Evolution of biotechnology sector in the Asia Pacific, along with the favorable government initiatives, Asia Pacific is expected to show the fastest growth rate during the forecast period

A few of the major players in the market are F. Hoffmann-La Roche Ltd; Bio-Rad Laboratories, Inc.; Becton, Dickinson and Company; Novartis AG; Beckman Coulter, Inc.; bioMerieux SA; Abbott Laboratories; Siemens Healthineers, and Illumina, Inc.

 Table of Contents

Chapter 1 Research Methodology
                    1.1 Information Procurement
                    1.2 Data Analysis
                    1.3 Approaches for Market Estimation
                         1.3.1 Approach 1: Demand Analysis& Bottom up Approach
                         1.3.2 Approach 2: Top-down market estimation
                         1.3.3 Approach 3: Commodity flow and bottom-up market estimation
                         1.3.4 Approach 4: KoL perspective-based market sizing
Chapter 2 Executive Summary
                    2.1 Market Segmentation& Scope
Chapter 3 Nucleic Acid Amplification Testing Market Variables, Trends & Scope
                    3.1 Market Segmentation& Scope
                         3.1.1 Market driver analysis
                         3.1.2 Market restraint analysis
                    3.2 Penetration & Growth Prospect Mapping
                    3.3 Nucleic Acid Amplification Testing Systems-SWOT Analysis, by Factor (political & legal, economic and technological)
                    3.4 Industry Analysis - Porter's
Chapter 4 Nucleic Acid Amplification Testing: Application Estimates & Trend Analysis
                    4.1 Nucleic Acid Amplification Testing Market: Application Movement Analysis
                    4.2 Infectious Disease
                         4.2.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
                         4.2.2 Virus
                              4.2.2.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
                         4.2.3 Bacteria
                              4.2.3.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
                         4.2.4 Others
                              4.2.4.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
                    4.3 Cancer
                         4.3.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
                    4.4 Personalized Medicine
                         4.4.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
                    4.5 Genetic and Mitochondrial Disorders
                         4.5.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
Chapter 5 Nucleic Acid Amplification Testing: Technique Estimates & Trend Analysis
                    5.1 Nucleic Acid Amplification Testing Market: Technique Movement Analysis
                    5.2 Target Amplification Systems
                         5.2.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
                    5.3 Probe Amplification Systems
                         5.3.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
                    5.4 Signal Amplification Systems
                         5.4.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
Chapter 6 Nucleic Acid Amplification Testing: Regional Estimates & Trend Analysis, by Application, and Techniques
                    6.1 Nucleic Acid Amplification Testing: Region Movement Analysis
                    6.2 North America
                         6.2.1 Market Estimates and Forecast, 2014 - 2024 (USD Million)
                         6.2.2 U.S.
                              6.2.2.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
                         6.2.3 Canada
                              6.2.3.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
                    6.3 Europe
                         6.3.1 Europe nucleic acid amplification testing market, 2014 - 2025 (USD Million)
                         6.3.2 U.K.
                              6.3.2.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
                         6.3.3 Germany
                              6.3.3.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
                    6.4 Asia Pacific
                         6.4.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
                         6.4.2 China
                              6.4.2.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
                         6.4.3 India
                              6.4.3.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
                    6.5 Latin America
                         6.5.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
                         6.5.2 Brazil
                              6.5.2.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
                         6.5.3 Mexico
                              6.5.3.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
                    6.6 Middle East and Africa (MEA)
                         6.6.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
                         6.6.2 South Africa
                              6.6.2.1 Market Estimates and Forecast, 2014 - 2025 (USD Million)
Chapter 7 Competitive Landscape
                    7.1 Strategy Framework
                    7.2 Market Participation Categorization
                    7.3 Company Profiles
                         7.3.1 Becton, Dickinson and Company
                              7.3.1.1 Company overview
                              7.3.1.2 Financial performance
                              7.3.1.3 Product benchmarking
                              7.3.1.4 Strategic initiatives
                         7.3.2 Hoffmann-La Roche Ltd
                              7.3.2.1 Company overview
                              7.3.2.2 Financial performance
                              7.3.2.3 Product benchmarking
                              7.3.2.4 Strategic initiatives
                         7.3.3 Siemens Healthcare GmbH
                              7.3.3.1 Company overview
                              7.3.3.2 Financial performance
                              7.3.3.3 Product benchmarking
                              7.3.3.4 Strategic initiatives
                         7.3.4 Bio-Rad Laboratories, Inc.
                              7.3.4.1 Company overview
                              7.3.4.2 Financial performance
                              7.3.4.3 Product benchmarking
                              7.3.4.4 Strategic initiatives
                         7.3.5 bioMerieux SA
                              7.3.5.1 Company overview
                              7.3.5.2 Financial performance
                              7.3.5.3 Product benchmarking
                              7.3.5.4 Strategic initiatives
                         7.3.6 Illumina, Inc.
                              7.3.6.1 Company overview
                              7.3.6.2 Financial performance
                              7.3.6.3 Product benchmarking
                              7.3.6.4 Strategic initiatives
                         7.3.7 Grifols SA
                              7.3.7.1 Company overview
                              7.3.7.2 Financial performance
                              7.3.7.3 Product benchmarking
                              7.3.7.4 Strategic initiatives
                         7.3.8 Beckman Coulter, Inc.
                              7.3.8.1 Company overview
                              7.3.8.2 Financial performance
                              7.3.8.3 Product benchmarking
                              7.3.8.4 Strategic initiatives
                         7.3.9 Abbott
                              7.3.9.1 Company overview
                              7.3.9.2 Financial performance
                              7.3.9.3 Product benchmarking
                              7.3.9.4 Strategic initiatives
                         7.3.10 Hologic, Inc.
                              7.3.10.1 Company overview
                              7.3.10.2 Financial performance
                              7.3.10.3 Product benchmarking
                              7.3.10.4 Strategic initiatives

List of Tables

TABLE 1 North America nucleic acid amplification testing market, by application, 2014 - 2025 (USD Million)
TABLE 2 North America infectious diseases market, by type 2014 - 2025 (USD Million)
TABLE 3 North America nucleic acid amplification testing market, by technique, 2014 - 2025 (USD Million)
TABLE 4 U.S. nucleic acid amplification testing market, by application, 2014 - 2025 (USD Million)
TABLE 5 U.S. infectious diseases market, by type 2014 - 2025 (USD Million)
TABLE 6 U.S. nucleic acid amplification testing market, by technique, 2014 - 2025 (USD Million)
TABLE 7 Canada nucleic acid amplification testing market, by application, 2014 - 2025 (USD Million)
TABLE 8 Canada infectious diseases market, by type 2014 - 2025 (USD Million)
TABLE 9 Canada nucleic acid amplification testing market, by technique, 2014 - 2025 (USD Million)
TABLE 10 Europe nucleic acid amplification testing market, by application, 2014 - 2025 (USD Million)
TABLE 11 Europe infectious diseases market, by type 2014 - 2025 (USD Million)
TABLE 12 Europe nucleic acid amplification testing market, by technique, 2014 - 2025 (USD Million)
TABLE 13 U.K. nucleic acid amplification testing market, by application, 2014 - 2025 (USD Million)
TABLE 14 U.K. infectious diseases market, by type 2014 - 2025 (USD Million)
TABLE 15 U.K. nucleic acid amplification testing market, by technique, 2014 - 2025 (USD Million)
TABLE 16 Germany nucleic acid amplification testing market, by application, 2014 - 2025 (USD Million)
TABLE 17 Germany infectious diseases market, by type 2014 - 2025 (USD Million)
TABLE 18 Germany nucleic acid amplification testing market, by technique, 2014 - 2025 (USD Million)
TABLE 19 Asia Pacific nucleic acid amplification testing market, by application, 2014 - 2025 (USD Million)
TABLE 20 Asia Pacific infectious diseases market, by type 2014 - 2025 (USD Million)
TABLE 21 Asia Pacific nucleic acid amplification testing market, by technique, 2014 - 2025 (USD Million)
TABLE 22 China nucleic acid amplification testing market, by application, 2014 - 2025 (USD Million)
TABLE 23 China infectious diseases market, by type 2014 - 2025 (USD Million)
TABLE 24 China nucleic acid amplification testing market, by technique, 2014 - 2025 (USD Million)
TABLE 25 India nucleic acid amplification testing market, by application, 2014 - 2025 (USD Million)
TABLE 26 India infectious diseases market, by type 2014 - 2025 (USD Million)
TABLE 27 India nucleic acid amplification testing market, by technique, 2014 - 2025 (USD Million)
TABLE 28 Latin America nucleic acid amplification testing market, by application, 2014 - 2025 (USD Million)
TABLE 29 Latin America infectious diseases market, by type 2014 - 2025 (USD Million)
TABLE 30 Latin America nucleic acid amplification testing market, by technique, 2014 - 2025 (USD Million)
TABLE 31 Brazil nucleic acid amplification testing market, by application, 2014 - 2025 (USD Million)
TABLE 32 Brazil infectious diseases market, by type 2014 - 2025 (USD Million)
TABLE 33 Brazil nucleic acid amplification testing market, by technique, 2014 - 2025 (USD Million)
TABLE 34 Mexico nucleic acid amplification testing market, by application, 2014 - 2025 (USD Million)
TABLE 35 Mexico infectious diseases market, by type 2014 - 2025 (USD Million)
TABLE 36 Mexico nucleic acid amplification testing market, by technique, 2014 - 2025 (USD Million)
TABLE 37 MEA nucleic acid amplification testing market, by application, 2014 - 2025 (USD Million)
TABLE 38 MEA infectious diseases market, by type 2014 - 2025 (USD Million)
TABLE 39 MEA nucleic acid amplification testing market, by technique, 2014 - 2025 (USD Million)
TABLE 40 South Africa nucleic acid amplification testing market, by application, 2014 - 2025 (USD Million)
TABLE 41 South Africa infectious diseases market, by type 2014 - 2025 (USD Million)
TABLE 42 South Africa nucleic acid amplification testing market, by technique, 2014 - 2025 (USD Million)